XML 90 R82.htm IDEA: XBRL DOCUMENT v3.22.1
STOCK-BASED COMPENSATION - RSAs (formerly PIUs), RSUs, RSUs - Founder's Award, Employee Warrants and Earnouts (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 20, 2021
Sep. 19, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Restricted stock awards            
SARs            
Outstanding, beginning (in shares)   10,513,291 10,513,291 10,513,291    
Granted prior to/after the Reverse Recapitalization (in shares) 0   0      
Vested prior to/after the Reverse Recapitalization (in shares) (16,645)   (3,079,371)      
Forfeited prior to/after the Reverse Recapitalization (in shares) (230,700)   0      
Conversion in connection with the Reverse Recapitalization (in shares)   (4,377,597)        
Outstanding, ending (in shares) 2,808,978     2,808,978 10,513,291  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]            
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)   $ 0.57 $ 0.57 $ 0.57    
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share) $ 0   0   $ 0.83 $ 0.59
Vested prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share) 1.97   0.49      
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share) 1.10   $ 0      
Conversion in connection with the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)   $ 0        
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share) $ 1.01     $ 1.01 $ 0.57  
Restricted stock units            
SARs            
Outstanding, beginning (in shares)   0 0 0    
Granted prior to/after the Reverse Recapitalization (in shares)       8,905,388 0 0
Vested prior to/after the Reverse Recapitalization (in shares)       (37,500)    
Forfeited prior to/after the Reverse Recapitalization (in shares)       (8,681)    
Outstanding, ending (in shares) 8,859,207     8,859,207 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]            
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)   $ 0 $ 0 $ 0    
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)       5.71    
Vested prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)       5.70    
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)       5.70    
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share) $ 5.71     $ 5.71 $ 0  
Restricted stock units - founder's award            
SARs            
Outstanding, beginning (in shares)   0 0 0    
Granted prior to/after the Reverse Recapitalization (in shares)       9,258,298    
Vested prior to/after the Reverse Recapitalization (in shares)       0    
Forfeited prior to/after the Reverse Recapitalization (in shares)       0    
Outstanding, ending (in shares) 9,258,298     9,258,298 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]            
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)   $ 0 $ 0 $ 0    
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)       5.06    
Vested prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)       0    
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)       0    
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share) $ 5.06     $ 5.06 $ 0  
Employee Warrants            
SARs            
Outstanding, beginning (in shares)   0 0 0    
Granted prior to/after the Reverse Recapitalization (in shares)       188,958    
Exercised prior to/after the Reverse Recapitalization (in shares)       0    
Forfeited prior to/after the Reverse Recapitalization (in shares)       0    
Expired prior to/after the Reverse Recapitalization (in shares)       0    
Outstanding, ending (in shares) 188,958     188,958 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]            
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)   $ 0 $ 0 $ 0    
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)       11.50    
Exercised prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)       0    
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)       0    
Expired prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)       0    
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share) $ 11.50     $ 11.50 $ 0  
Outstanding, Weighted-Average Remaining Contractual Terms in Years       4 days 17 hours    
Outstanding, Aggregate Intrinsic Value $ 0     $ 0    
Employee Earnouts            
SARs            
Outstanding, beginning (in shares)   0 0 0    
Granted prior to/after the Reverse Recapitalization (in shares)       309,179    
Vested prior to/after the Reverse Recapitalization (in shares)       0    
Forfeited prior to/after the Reverse Recapitalization (in shares)       0    
Outstanding, ending (in shares) 309,179     309,179 0  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]            
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)   $ 0 $ 0 $ 0    
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)       8.94    
Vested prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)       0    
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)       0    
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share) $ 8.94     $ 8.94 $ 0